Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Molecular Targeted Therapy"" wg kryterium: Temat


Tytuł:
Revolutionizing cancer care strategies: immunotherapy, gene therapy, and molecular targeted therapy.
Autorzy:
Zafar A; Department of Biosciences, COMSATS University, Islamabad, 45550, Pakistan.
Khan MJ; Department of Biosciences, COMSATS University, Islamabad, 45550, Pakistan.
Abu J; Hazm Mebaireek General Hospital, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar.
Naeem A; Qatar University Health, Qatar University, P.O. Box 2713, Doha, Qatar. .
Pokaż więcej
Źródło:
Molecular biology reports [Mol Biol Rep] 2024 Jan 28; Vol. 51 (1), pp. 219. Date of Electronic Publication: 2024 Jan 28.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Molecular Targeted Therapy*
Neoplasms*/therapy
Neoplasms*/drug therapy
Humans ; Immunotherapy ; Genetic Therapy
Czasopismo naukowe
Tytuł:
Molecular Targeting of the Human Epidermal Growth Factor Receptor-2 (HER2) Genes across Various Cancers.
Autorzy:
Rubin E; Memorial Cancer Institute, Pembroke Pines, FL 33028, USA.
Shan KS; Memorial Cancer Institute, Pembroke Pines, FL 33028, USA.
Dalal S; Memorial Cancer Institute, Pembroke Pines, FL 33028, USA.
Vu DUD; Memorial Cancer Institute, Pembroke Pines, FL 33028, USA.
Milillo-Naraine AM; Memorial Cancer Institute, Pembroke Pines, FL 33028, USA.
Guaqueta D; Memorial Cancer Institute, Pembroke Pines, FL 33028, USA.
Ergle A; Memorial Cancer Institute, Pembroke Pines, FL 33028, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 15; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 15.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Molecular Targeted Therapy*
Breast Neoplasms*/drug therapy
Breast Neoplasms*/genetics
Humans ; Female ; Receptor, ErbB-2/genetics ; Genes, erbB-1
Czasopismo naukowe
Tytuł:
Back to Broad? How Molecular Profiling Facilitates Targeted Therapies of Overlapping Phenotypes.
Autorzy:
Eyerich K; Division of Dermatology and Venereology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Dermatology and Venereology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Garzorz-Stark N; Division of Dermatology and Venereology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany. Electronic address: .
Pokaż więcej
Źródło:
The Journal of investigative dermatology [J Invest Dermatol] 2024 Jan; Vol. 144 (1), pp. 3-4. Date of Electronic Publication: 2023 Sep 14.
Typ publikacji:
Journal Article; Comment
MeSH Terms:
Molecular Targeted Therapy*
Phenotype
Czasopismo naukowe
Tytuł:
Molecular-based targeted therapies in patients with hepatocellular carcinoma and hepato-cholangiocarcinoma refractory to atezolizumab/bevacizumab.
Autorzy:
Limousin W; Cordeliers Research Center, Sorbonne Université, Inserm, Université de Paris, team « Functional Genomics of Solid Tumors », Equipe labellisée Ligue Nationale Contre le Cancer, Labex OncoImmunology, F-75006 Paris, France.
Laurent-Puig P; Cordeliers Research Center, INSERM, CNRS SNC 5096, Sorbonne Université, Université de Paris Cité, Paris, France; Multi-site Medical Biology Laboratory SeqOIA, Paris, France; Institut of Cancer Paris CARPEM, AP-HP-Hôpital Européen Georges Pompidou, Paris, France.
Ziol M; Cordeliers Research Center, Sorbonne Université, Inserm, Université de Paris, team « Functional Genomics of Solid Tumors », Equipe labellisée Ligue Nationale Contre le Cancer, Labex OncoImmunology, F-75006 Paris, France; Pathology Department, and Centre de ressources biologiques (BB-0033-00027) Hôpitaux Universitaires Paris-Seine-Saint-Denis Avicenne Avicenne Hospital, APHP, Bobigny, France.
Ganne-Carrié N; Cordeliers Research Center, Sorbonne Université, Inserm, Université de Paris, team « Functional Genomics of Solid Tumors », Equipe labellisée Ligue Nationale Contre le Cancer, Labex OncoImmunology, F-75006 Paris, France; Liver Unit, Avicenne Hospital, APHP, Bobigny, France.
Nahon P; Cordeliers Research Center, Sorbonne Université, Inserm, Université de Paris, team « Functional Genomics of Solid Tumors », Equipe labellisée Ligue Nationale Contre le Cancer, Labex OncoImmunology, F-75006 Paris, France; Institut of Cancer Paris CARPEM, AP-HP-Hôpital Européen Georges Pompidou, Paris, France.
Ait-Omar A; Gastroenterology Unit, Avicenne Hospital, APHP, Bobigny, France.
Seror O; Cordeliers Research Center, Sorbonne Université, Inserm, Université de Paris, team « Functional Genomics of Solid Tumors », Equipe labellisée Ligue Nationale Contre le Cancer, Labex OncoImmunology, F-75006 Paris, France; Interventional Radiology Unit, Avicenne Hospital, APHP, Bobigny, France.
Sidali S; Cordeliers Research Center, Sorbonne Université, Inserm, Université de Paris, team « Functional Genomics of Solid Tumors », Equipe labellisée Ligue Nationale Contre le Cancer, Labex OncoImmunology, F-75006 Paris, France; Liver Unit, Paris Cité University, Beaujon Hospital, APHP, DMU DIGEST, Clichy, France.
Campani C; Cordeliers Research Center, Sorbonne Université, Inserm, Université de Paris, team « Functional Genomics of Solid Tumors », Equipe labellisée Ligue Nationale Contre le Cancer, Labex OncoImmunology, F-75006 Paris, France; Department of Experimental and Clinical Medicine, Internal Medicine and Hepatology Unit, University of Florence, Florence, Italy.
Blanc P; Multi-site Medical Biology Laboratory SeqOIA, Paris, France.
Lermine A; Multi-site Medical Biology Laboratory SeqOIA, Paris, France.
Marisa L; Multi-site Medical Biology Laboratory SeqOIA, Paris, France.
Zucman-Rossi J; Cordeliers Research Center, Sorbonne Université, Inserm, Université de Paris, team « Functional Genomics of Solid Tumors », Equipe labellisée Ligue Nationale Contre le Cancer, Labex OncoImmunology, F-75006 Paris, France.
Nault JC; Cordeliers Research Center, Sorbonne Université, Inserm, Université de Paris, team « Functional Genomics of Solid Tumors », Equipe labellisée Ligue Nationale Contre le Cancer, Labex OncoImmunology, F-75006 Paris, France; Liver Unit, Avicenne Hospital, APHP, Bobigny, France. Electronic address: .
Pokaż więcej
Źródło:
Journal of hepatology [J Hepatol] 2023 Dec; Vol. 79 (6), pp. 1450-1458. Date of Electronic Publication: 2023 Aug 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Bile Duct Neoplasms*/drug therapy
Bile Duct Neoplasms*/genetics
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/genetics
Cholangiocarcinoma*/drug therapy
Cholangiocarcinoma*/genetics
Liver Neoplasms*/drug therapy
Liver Neoplasms*/genetics
Molecular Targeted Therapy*
Female ; Humans ; Male ; Middle Aged ; Bevacizumab/therapeutic use ; Bile Ducts, Intrahepatic ; Everolimus ; Pilot Projects ; Precision Medicine ; Antineoplastic Agents/therapeutic use
Czasopismo naukowe
Tytuł:
Responsive nanosystems for targeted therapy of ulcerative colitis: Current practices and future perspectives.
Autorzy:
Chen M; Department of Colorectal Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Lan H; Department of Surgical Oncology, Hangzhou Cancer Hospital, Hangzhou, Zhejiang, China.
Jin K; Department of Colorectal Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, China.
Chen Y; Department of Colorectal Surgery, Xinchang People's Hospital, Affiliated Xinchang Hospital, Wenzhou Medical University, Xinchang, Zhejiang, China.
Pokaż więcej
Źródło:
Drug delivery [Drug Deliv] 2023 Dec; Vol. 30 (1), pp. 2219427.
Typ publikacji:
Journal Article
MeSH Terms:
Colitis, Ulcerative*/drug therapy
Molecular Targeted Therapy*
Humans ; Drug Carriers ; Drug Delivery Systems/methods ; Nanoparticles ; Quality of Life
Czasopismo naukowe
Tytuł:
From target discovery to clinical drug development with human genetics.
Autorzy:
Trajanoska K; Canada Excellence Research Chair in Genomic Medicine, Department of Human Genetics, Faculty of Medicine and Health Sciences, Victor Phillip Dahdaleh Institute of Genomic Medicine, McGill University, Montreal, Quebec, Canada.
Bhérer C; Canada Excellence Research Chair in Genomic Medicine, Department of Human Genetics, Faculty of Medicine and Health Sciences, Victor Phillip Dahdaleh Institute of Genomic Medicine, McGill University, Montreal, Quebec, Canada.
Taliun D; Canada Excellence Research Chair in Genomic Medicine, Department of Human Genetics, Faculty of Medicine and Health Sciences, Victor Phillip Dahdaleh Institute of Genomic Medicine, McGill University, Montreal, Quebec, Canada.
Zhou S; Canada Excellence Research Chair in Genomic Medicine, Department of Human Genetics, Faculty of Medicine and Health Sciences, Victor Phillip Dahdaleh Institute of Genomic Medicine, McGill University, Montreal, Quebec, Canada.
Richards JB; Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.; Department of Epidemiology and Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.
Mooser V; Canada Excellence Research Chair in Genomic Medicine, Department of Human Genetics, Faculty of Medicine and Health Sciences, Victor Phillip Dahdaleh Institute of Genomic Medicine, McGill University, Montreal, Quebec, Canada. .
Pokaż więcej
Źródło:
Nature [Nature] 2023 Aug; Vol. 620 (7975), pp. 737-745. Date of Electronic Publication: 2023 Aug 23.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Drug Development*/statistics & numerical data
Human Genetics*
Molecular Targeted Therapy*/methods
Molecular Targeted Therapy*/statistics & numerical data
Humans ; Drug Approval/statistics & numerical data ; Therapies, Investigational/statistics & numerical data ; Rare Diseases/genetics ; Rare Diseases/therapy ; Germ-Line Mutation ; Time Factors
Czasopismo naukowe
Tytuł:
A detailed kinetic model of glycolysis in Plasmodium falciparum-infected red blood cells for antimalarial drug target identification.
Autorzy:
van Niekerk DD; Department of Biochemistry, Stellenbosch University, Matieland, South Africa.
du Toit F; Department of Biochemistry, Stellenbosch University, Matieland, South Africa.
Green K; Department of Biochemistry, Stellenbosch University, Matieland, South Africa.
Palm D; Department of Biochemistry, Stellenbosch University, Matieland, South Africa.
Snoep JL; Department of Biochemistry, Stellenbosch University, Matieland, South Africa; Molecular Cell Biology, Vrije Universiteit, Amsterdam, The Netherlands. Electronic address: .
Pokaż więcej
Źródło:
The Journal of biological chemistry [J Biol Chem] 2023 Sep; Vol. 299 (9), pp. 105111. Date of Electronic Publication: 2023 Jul 29.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antimalarials*/pharmacology
Antimalarials*/therapeutic use
Antimalarials*/metabolism
Erythrocytes*/drug effects
Erythrocytes*/metabolism
Erythrocytes*/parasitology
Glycolysis*/drug effects
Malaria, Falciparum*/metabolism
Malaria, Falciparum*/parasitology
Plasmodium falciparum*/metabolism
Plasmodium falciparum*/pathogenicity
Plasmodium falciparum*/physiology
Molecular Targeted Therapy*/methods
Models, Biological*
Humans ; Acidosis, Lactic ; Glucose/metabolism ; Hypoglycemia ; Kinetics ; Trophozoites/pathogenicity ; Trophozoites/physiology ; Parasite Load
Czasopismo naukowe
Tytuł:
Neighborhood disadvantage, insurance status, and molecular profiling of patients with acute myeloid leukemia.
Autorzy:
Bade R; School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.
Banaszak LG; Department of Medicine; University of Wisconsin-Madison, Madison, WI 53705, USA. Electronic address: .
Osman F; Department of Medicine; University of Wisconsin-Madison, Madison, WI 53705, USA.
Cabral P; Department of Medicine; University of Wisconsin-Madison, Madison, WI 53705, USA.
Hassan A; Department of Medicine; University of Wisconsin-Madison, Madison, WI 53705, USA.
Stepanovic A; Department of Medicine; University of Wisconsin-Madison, Madison, WI 53705, USA.
Reinig E; Department of Pathology and Laboratory Medicine; University of Wisconsin-Madison, Madison, WI 53705, USA.
Mattison RJ; Department of Medicine; University of Wisconsin-Madison, Madison, WI 53705, USA.
Pokaż więcej
Źródło:
Leukemia research [Leuk Res] 2023 Aug; Vol. 131, pp. 107326. Date of Electronic Publication: 2023 May 24.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Leukemia, Myeloid, Acute*/genetics
Leukemia, Myeloid, Acute*/therapy
Healthcare Disparities*
Molecular Targeted Therapy*/economics
Insurance Coverage*
Humans ; Retrospective Studies ; Neighborhood Characteristics ; Socioeconomic Factors ; Male ; Female ; Adult ; Survival Analysis ; Social Deprivation
Czasopismo naukowe
Tytuł:
Targeted therapy and immunotherapy for T cell acute lymphoblastic leukemia/lymphoma.
Autorzy:
Huang YH; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, 215006, China.
Wan CL; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, 215006, China.
Dai HP; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China. .; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, 215006, China. .
Xue SL; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China. .; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, 215006, China. .
Pokaż więcej
Źródło:
Annals of hematology [Ann Hematol] 2023 Aug; Vol. 102 (8), pp. 2001-2013. Date of Electronic Publication: 2023 May 25.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Immunotherapy*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/therapy
Lymphoma*/therapy
Molecular Targeted Therapy*
Humans ; T-Lymphocytes
Czasopismo naukowe
Tytuł:
Glutamine and amino acid metabolism as a prognostic signature and therapeutic target in endometrial cancer.
Autorzy:
Zhai L; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.
Yang X; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.
Cheng Y; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.
Wang J; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Aug; Vol. 12 (15), pp. 16337-16358. Date of Electronic Publication: 2023 Jun 30.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Endometrial Neoplasms*/drug therapy
Endometrial Neoplasms*/enzymology
Endometrial Neoplasms*/pathology
Glutamine*/genetics
Glutamine*/metabolism
Phosphoglycerate Dehydrogenase*/antagonists & inhibitors
Phosphoglycerate Dehydrogenase*/genetics
Molecular Targeted Therapy*
Prognosis ; Humans ; Female ; Piperazines/therapeutic use ; Thioamides/therapeutic use ; Pyridines/therapeutic use ; Cell Line, Tumor ; Animals ; Mice ; Mice, Nude ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł:
Heat shock protein 90 (HSP90) inhibitors in gastrointestinal cancer: where do we currently stand?-A systematic review.
Autorzy:
Magyar CTJ; Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Switzerland.
Vashist YK; Hamburg, Germany.
Stroka D; Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Switzerland.
Kim-Fuchs C; Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Switzerland.
Berger MD; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Switzerland.
Banz VM; Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Switzerland. .
Pokaż więcej
Źródło:
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2023 Aug; Vol. 149 (10), pp. 8039-8050. Date of Electronic Publication: 2023 Mar 26.
Typ publikacji:
Journal Article; Systematic Review
MeSH Terms:
HSP90 Heat-Shock Proteins*/antagonists & inhibitors
HSP90 Heat-Shock Proteins*/metabolism
Gastrointestinal Neoplasms*/drug therapy
Gastrointestinal Neoplasms*/metabolism
Gastrointestinal Neoplasms*/mortality
Molecular Targeted Therapy*
Antineoplastic Agents*
Humans ; Isoxazoles/adverse effects ; Isoxazoles/therapeutic use ; Resorcinols/adverse effects ; Resorcinols/therapeutic use ; Clinical Trials as Topic
Czasopismo naukowe
Tytuł:
Clinicopathologic Analysis of Micropapillary Urothelial Carcinoma of the Upper Urinary Tract: Implications for HER2-Targeted Therapy.
Autorzy:
Chou LP; Department of Urology, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi City, Taiwan.
Hsu CW; Department of Pathology, National Cheng Kung University Hospital, Tainan, Taiwan.
Yang SF; Department of Pathology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Pathology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Lee CT; Department of Pathology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Ou YC; Department of Urology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Lin KC; Department of Urology, National Cheng Kung University Hospital, Tainan, Taiwan.
Hu CY; Department of Urology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Jou YC; Division of Urology, Department of Surgery, St Martin De Porres Hospital, Chia-Yi City, Taiwan. Electronic address: .
Tsai YS; Department of Urology, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Electronic address: .
Chow NH; Department of Pathology, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Electronic address: .
Pokaż więcej
Źródło:
Clinical genitourinary cancer [Clin Genitourin Cancer] 2023 Aug; Vol. 21 (4), pp. 508.e1-508.e10. Date of Electronic Publication: 2023 Apr 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Molecular Targeted Therapy*
Urologic Neoplasms/diagnosis ; Urologic Neoplasms/drug therapy ; Urologic Neoplasms/physiopathology ; Carcinoma, Papillary/diagnosis ; Carcinoma, Papillary/drug therapy ; Carcinoma, Papillary/physiopathology ; Genes, erbB-2/genetics ; Case-Control Studies ; Humans ; Male ; Female ; Middle Aged ; Aged ; Aged, 80 and over ; Gene Expression Regulation, Neoplastic ; Neoplasm Invasiveness/genetics ; Immunohistochemistry ; Biomarkers, Tumor/metabolism
Czasopismo naukowe
Tytuł:
Targeting G Protein-Coupled Receptors in the Treatment of Parkinson's Disease.
Autorzy:
Jones-Tabah J; Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, 3801 University Street, Montreal, QC H3A 2B4, Canada. Electronic address: .
Pokaż więcej
Źródło:
Journal of molecular biology [J Mol Biol] 2023 Jun 15; Vol. 435 (12), pp. 167927. Date of Electronic Publication: 2022 Dec 21.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Parkinson Disease*/drug therapy
Parkinson Disease*/metabolism
Receptors, G-Protein-Coupled*/metabolism
Molecular Targeted Therapy*
Humans ; Dopaminergic Neurons/metabolism ; Levodopa/therapeutic use ; Levodopa/metabolism ; Receptors, Dopamine/metabolism
Czasopismo naukowe
Tytuł:
The role of HMGB1 in COVID-19-induced cytokine storm and its potential therapeutic targets: A review.
Autorzy:
Wulandari S; Doctorate Program of Medicine and Health Science, Faculty of Medicine, Public Health and Nursing Universitas Gadjah Mada, Yogyakarta, Indonesia.; Department of Physiology, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia.
Hartono; Department of Physiology, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia.
Wibawa T; Department of Microbiology, Faculty of Medicine, Public Health and Nursing Universitas Gadjah Mada, Yogyakarta, Indonesia.
Pokaż więcej
Źródło:
Immunology [Immunology] 2023 Jun; Vol. 169 (2), pp. 117-131. Date of Electronic Publication: 2023 Jan 11.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Cytokine Release Syndrome*/drug therapy
Cytokine Release Syndrome*/immunology
Cytokine Release Syndrome*/virology
COVID-19*/complications
COVID-19*/immunology
HMGB1 Protein*/antagonists & inhibitors
HMGB1 Protein*/metabolism
RNA, Viral*/metabolism
SARS-CoV-2*/metabolism
Molecular Targeted Therapy*
Antiviral Agents*/pharmacology
Antiviral Agents*/therapeutic use
COVID-19 Drug Treatment*
Humans ; Host Microbial Interactions/immunology
Czasopismo naukowe
Tytuł:
Role of Midkine in Cancer Drug Resistance: Regulators of Its Expression and Its Molecular Targeting.
Autorzy:
Saikia M; Department of Radiation Oncology, Washington University in St. Louis School of Medicine, St. Louis, MO 63108, USA.
Cheung N; Department of Radiation Oncology, Washington University in St. Louis School of Medicine, St. Louis, MO 63108, USA.
Singh AK; Department of Radiation Oncology, Washington University in St. Louis School of Medicine, St. Louis, MO 63108, USA.
Kapoor V; Department of Radiation Oncology, Washington University in St. Louis School of Medicine, St. Louis, MO 63108, USA.; Siteman Cancer Center, St. Louis, MO 63108, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 May 14; Vol. 24 (10). Date of Electronic Publication: 2023 May 14.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Molecular Targeted Therapy*
Neoplasms*/drug therapy
Neoplasms*/genetics
Humans ; Midkine ; Cytokines/metabolism ; Drug Resistance, Neoplasm/genetics
Czasopismo naukowe
Tytuł:
CX3CL1 Pathway as a Molecular Target for Treatment Strategies in Alzheimer's Disease.
Autorzy:
Bivona G; Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, 90127 Palermo, Italy.
Iemmolo M; Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Viale delle Scienze, Ed. 16, 90128 Palermo, Italy.
Ghersi G; Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Viale delle Scienze, Ed. 16, 90128 Palermo, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 May 04; Vol. 24 (9). Date of Electronic Publication: 2023 May 04.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Alzheimer Disease*/physiopathology
Alzheimer Disease*/therapy
Molecular Targeted Therapy*/trends
Chemokine CXCL1*/metabolism
Signal Transduction*
Microglia/physiology ; CX3C Chemokine Receptor 1/metabolism
Czasopismo naukowe
Tytuł:
How I treat endocrine-dependent metastatic breast cancer.
Autorzy:
Gombos A; Department of Medical Oncology Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
Goncalves A; Institut Paoli Calmettes, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm U1068, CNRS U7258, Aix Marseille University, Marseille, France.
Curigliano G; European Institute of Oncology, University of Milano, Milano, Italy.
Bartsch R; Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Kyte JA; Department of Oncology, Oslo University Hospital, Oslo, Norway.
Ignatiadis M; Department of Medical Oncology Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
Awada A; Department of Medical Oncology Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: .
Pokaż więcej
Źródło:
ESMO open [ESMO Open] 2023 Apr; Vol. 8 (2), pp. 100882. Date of Electronic Publication: 2023 Feb 17.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Breast Neoplasms*/drug therapy
Breast Neoplasms*/pathology
Molecular Targeted Therapy*/trends
Female ; Humans ; Immunoconjugates/therapeutic use ; Drug Resistance, Neoplasm ; Antineoplastic Agents/therapeutic use ; Mutation ; Selective Estrogen Receptor Modulators/therapeutic use
Czasopismo naukowe
Tytuł:
Recent advances in the molecular targeted drugs for prostate cancer.
Autorzy:
Gao P; Department of Urology, Guizhou Provincial People's Hospital, Guiyang, 550002, China.
Li T; Department of Urology, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550002, China.
Zhang K; Department of Urology, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, 550002, China.
Luo G; Department of Urology, Guizhou Provincial People's Hospital, Guiyang, 550002, China. .
Pokaż więcej
Źródło:
International urology and nephrology [Int Urol Nephrol] 2023 Apr; Vol. 55 (4), pp. 777-789. Date of Electronic Publication: 2023 Jan 31.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
Molecular Targeted Therapy*/adverse effects
Prostatic Neoplasms*/drug therapy
Humans ; Male ; Prospective Studies ; Retrospective Studies ; Prostate
Czasopismo naukowe
Tytuł:
Emerging therapeutic strategies in cancer therapy by HDAC inhibition as the chemotherapeutic potent and epigenetic regulator.
Autorzy:
Karati D; Department of Pharmaceutical Technology, School of Pharmacy, Techno India University, Kolkata, 700091, India.
Mukherjee S; Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata, 124 B.L. Saha Road, Kolkata, West Bengal, 700053, India.
Roy S; Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata, 124 B.L. Saha Road, Kolkata, West Bengal, 700053, India. .
Pokaż więcej
Źródło:
Medical oncology (Northwood, London, England) [Med Oncol] 2024 Mar 05; Vol. 41 (4), pp. 84. Date of Electronic Publication: 2024 Mar 05.
Typ publikacji:
Journal Article; Review
MeSH Terms:
MicroRNAs*/genetics
Neoplasms*/drug therapy
Neoplasms*/genetics
Humans ; Histone Deacetylase Inhibitors/pharmacology ; Histone Deacetylase Inhibitors/therapeutic use ; Molecular Targeted Therapy ; Epigenesis, Genetic ; Histone Deacetylases
Czasopismo naukowe
Tytuł:
A generalized calibrated Bayesian hierarchical modeling approach to basket trials with multiple endpoints.
Autorzy:
Chi X; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Yuan Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Yu Z; Department of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.; SJTU-Yale Joint Center for Biostatistics and Data Science, Shanghai Jiao Tong University, Shanghai, China.
Lin R; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Pokaż więcej
Źródło:
Biometrical journal. Biometrische Zeitschrift [Biom J] 2024 Mar; Vol. 66 (2), pp. e2300122.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasms*/drug therapy
Humans ; Bayes Theorem ; Computer Simulation ; Molecular Targeted Therapy ; Research Design
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies